Learn about the automated insulin delivery system's features, how it works, what it costs — and get the latest news. Vertex Releases New Data on Potential Cure for Type 1 Diabetes A cure has long been ...
The FDA has approved Eversense 365, a new continuous glucose monitor (CGM) from Senseonics, for people with diabetes who are 18 years of age or older. The Eversense 365 has an implantable CGM sensor ...
CGM use for people with type 2 diabetes led to significant improvements in glucose control and reduced hospitalization. Automated insulin delivery device use was shown to improve time in range, lower ...